Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraphene Nanochem Regulatory News (GRPH)

  • There is currently no data for GRPH

Operations and Strategy Update

29 Mar 2011 13:58

RNS Number : 8353D
Biofutures International plc
29 March 2011
 

 

 

29 March 2011

 

 

Biofutures International plc

 

("Biofutures" or the "Group")

 

Operations and Strategy Update

 

Operations Update

 

Biofutures is pleased to announce that feedstock supply agreements have been executed between its subsidiary, Zurex Corporation Sdn. Bhd. ("Zurex"), and two suppliers of Crude Palm Oil (CPO), namely the Teck Guan Group and CC Palm Trading Sdn Bhd. In addition, an off-take / contract manufacturing memorandum of understanding has been signed between Zurex and CC Palm Trading Sdn Bhd.

 

As prices of CPO have been highly volatile in the first three months of 2011, Zurex has been extremely cautious in its refining approach in the view of optimising the use of its resources and to avoid any unwarranted losses. These agreements should help reduce the impact of such volatility in the longer term.

 

The Group is also pleased to announce that, on the average, specifications of RBD Palm Oil produced by the Zurex refinery exceeds that of the Palm Oil Refiners Association of Malaysia (PORAM), an internationally accepted, Malaysian Palm Oil Board standard, as shown below:

 

RBD PALM OIL (RBD Palm Oil) PORAM Spec Zurex Spec

 

Free Fatty Acid (FFA) (As Palmitic) 0.1% Max 0.04%

Moisture & Impurities (M&I) 0.1% 0.02%

Peroxide Value 1.5 Meg/Kg Max 0.87 Meg/Kg

Iodine Value 50 -55 Meg/Kg 52.1 Meg/Kg

M.Pt (AOCS Cc3-25) 33 - 39C 34C

Colour (5 1/4" Lovibond Cell) 3 Red Max 2.2 Red

 

Strategy Update

 

In view of the extreme volatility nature of the feedstock prices, Biofutures has started exploring the viability of owning its own plantation. In addition, the Group is exploring the possibility of collaborating with reputable process plant suppliers to consider other downstream activities such as further fractioning of RBD Palm Oil into RBD Palm Olein as well as to produce niche and high valued derivatives that will complement the activities and revenue of our refinery.

 

 

For further information, please contact:

 

Biofutures International plc

Tel: + 603 6203 5136

Joe Wong, Chief Executive Officer

www.biofuturesplc.com

 

Daniel Stewart & Company plc

Tel: + 44 (0) 20 7776 6550

Oliver Rigby/Antony Legge/Colin Rowbury

www.danielstewart.co.uk

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAADNASXFEFF
Date   Source Headline
5th Dec 20062:39 pmRNSHolding(s) in Company
1st Dec 20062:48 pmRNSHolding(s) in Company
30th Nov 20069:20 amRNSHolding(s) in Company
29th Nov 200612:07 pmRNSHolding(s) in Company
23rd Nov 20061:43 pmRNSEGM Statement
21st Nov 20067:00 amRNSChange of Registered Address
2nd Nov 200612:33 pmRNSDirector/PDMR Shareholding
1st Nov 20062:10 pmRNSDirector/PDMR Shareholding
1st Nov 200611:40 amRNSSchedule 1 - Biofutures Int
30th Oct 20067:01 amRNSAcquisition
30th Oct 20067:01 amRNSRestoration - Biofutures Intl
22nd Sep 20067:00 amRNSMaiden Interim Results
25th Aug 20063:00 pmRNSAppt. of Finance Director
28th Jul 20062:43 pmRNSConditional Agreement
19th Jun 20069:56 amRNSHolding(s) in Company
1st Jun 200611:45 amRNSSuspension - Biofutures Intl
1st Jun 200611:45 amRNSre Press Speculation
24th May 20063:08 pmRNSHolding(s) in Company
24th May 20067:01 amRNSHolding(s) in Company
17th May 20062:45 pmRNSHolding(s) in Company
17th May 200610:19 amRNSHolding(s) in Company
15th May 200611:38 amRNSHolding(s) in Company
15th May 200610:56 amRNSHolding(s) in Company
11th May 200612:10 pmRNSHolding(s) in Company
5th May 20061:39 pmRNSDirector shareholding
5th May 200611:10 amRNSHolding(s) in Company
5th May 20069:00 amRNSPlacing & Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.